ABBV - Company ID 0001551152
The table below shows AbbVie Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B | $8.45B |
| Short-term investments | $28.00M | $31.00M | $2.00M | $28.00M | $84.00M | $30.00M |
| Receivables | $12.59B | $10.92B | $11.15B | $11.25B | $9.98B | $8.82B |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | $3.13B | $3.31B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $29.06B |
| $25.58B |
| $33.00B |
| $28.46B |
| $27.93B |
| $24.17B |
| Property, plant & equipment | $5.63B | $5.13B | $4.99B | $4.93B | $5.11B | $5.25B |
| Goodwill | $35.64B | $34.96B | $32.29B | $32.16B | $32.38B | $33.12B |
| Total assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.56B |
| Accounts payable | $3.59B | $2.94B | $3.69B | $2.93B | $2.88B | $2.28B |
| Total current liabilities | $43.29B | $38.75B | $37.84B | $29.54B | $35.19B | $28.66B |
| Long-term debt | $64.50B | $66.84B | $59.24B | $63.13B | $75.96B | $84.95B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$15.49B | -$7.90B | -$1.00B | $4.78B | $3.13B | $1.05B |
| Total equity | -$3.27B | $3.33B | $10.36B | $17.25B | $15.41B | $13.08B |